Drug details

Empaveli (pegcetacoplan injection, for subcutaneous use)

type of Monoclonal Antibodies

Empaveli (pegcetacoplan) is a complement inhibitor used to treat adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• loss of appetite,
• itching,
• rash,
• vomiting,
• fever,
• shortness of breath,
• chills,
• severe headache,
• swelling
• abdominal pain,
• blood in your vomit, stool, or urine,
• redness or swelling of your skin,
• persistent sore throat, 
• delayed healing for burns or cuts,
• muscle or joint pain, and

The following drugs are related to Empaveli, either as a replacement or used together:

• Soliris (eculizumab)
• Ultomiris (ravulizumab-cwvz injection)